March 2016 Issue of Renal And Urology News
Renal & Urology News - March 2016 Issue
Nephrology Cover Articles
Study shows benefit of initiating epoetin beta therapy at hemoglobin levels not less than 10 g/dL in non-dialysis CKD patients.
In a study, the arrhythmia was 31% more likely to occur in PKD patients than non-PKD control patients.
Urology Cover Articles
In a phase 2 trial, etelcalcitide, a novel peptide agonist of the calcium-sensing receptor, significantly reduced parathyroid hormone levels.
The more frail the patient, the greater the likelihood of complications, such as hospital readmission and blood transfusion.
Any baldness is associated with a 56% higher risk of dying from the malignancy.
Tumors fall into 1 of 5 grade groups based on what pathologic findings indicate about prognosis.
Patients diagnosed with prostate cancer often struggle with their diagnosis.
An interview with David J. McConkey, PhD
News in Brief
Researchers identified the association in a cohort of older patients with reduced ejection fraction after acute myocardial infarction.
Racial difference found among patients undergoing robotic partial nephrectomy for renal tumors.
Exclusive rosiglitazone use is associated with 3-fold increased odds of bladder cancer.
Roux-en-Y gastric bypass surgery is associated with a 73% increased pooled RR of kidney stones.
Children with a ieGFR below 30 mL/min/1.73m2 have 4.5-fold greater odds of having a worse appetite.
More than 95% of women reported no stress urinary incontinence at 2-, 5-, and 10 year follow-up.
New document from the Office of Civil Rights reminds providers of their responsibilities and offers compliance tips.
Previous studies may have overlooked the placebo effect.
A recent review found little evidence to support severe lower urinary tract symptoms as a contraindication to TRT.
Men with a normal PSA upon repeat testing had a 78% lower risk of prostate cancer diagnosis than men with a second abnormal PSA result.
Study of peritoneal dialysis patients showed that they do not adjust binders to match the phosphate content of meals and snacks.
The risk of bladder outlet obstruction increased 34% per unit increase in serum PSA and decreased 23% per unit increase in maximal flow rate.
The study found no association with obesity, however, unlike previous studies.
Researchers observe significant improvements chronic and hemodialysis-induced vascular dysfunction.
No significant association found between phosphodiesterase type 5 inhibitor use and biochemical recurrence after radical treatment.
Risk is linked to small changes in serum creatinine and eGFR on the day after contrast exposure.
Serum total and free testosterone declined in men on hemodialysis who received a 6-month course of the drug for secondary hyperparathyroidism.
Many men are unaware of erectile function recovery time and problems with ejaculation.
At 7 years after kidney transplantation, belatacept recipients had lower risks of death and graft loss than those treated with cyclosporine.
The drugs do not appear to prevent progression to ESRD, new meta-analysis finds.
Antibiotics selected based on results of pre-biopsy rectal swab cultures.
In a phase 2 trial, roxadustat maintained hemoglobin levels over 19 weeks as well as epoetin alfa.
New findings suggest the medication induces beneficial renal structural changes.
Chronic kidney disease found to be 58% more likely to develop in individuals with than without the sleep disorder.
ERA-EDTA offers guidance on selecting patients for treatment, when to start the drug, dosing strategies, and other aspects of care.
Ablating only the prostate lobe with the tumor resulted in satisfactory mid-term functional outcomes, researchers reported.
Risk of being admitted for non-cancer conditions is 38% higher in the year after a PCa diagnosis compared with a year before.
Patients with preserved residual kidney function experience a survival benefit.
Study finds a 20% to 25% lower risk for early death over the long term.
In contrast, type 2 diabetes is associated with increased risks of bladder, kidney, liver, and other malignancies.
Renal and Urology News Articles
- FDA Recalls Drugs Containing Active Ingredient Valsartan
- Correcting Metabolic Acidosis May Preserve Muscle Mass
- Infection Risk Lower in Dialysis Patients With High, Normal Vitamin D
- Urine Cytology May Not Improve Hematuria Evaluation for Bladder Cancer
- Aggressive Therapy Warranted for Gleason 10 Prostate Cancer
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)